Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL	B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2026-03-27		NCT05147467

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ascentage Pharma Group Inc.	30

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hainan General Hospital	Haikou	China	21
Henan Cancer Hospital	Zhengzhou	China	57
Institute of Blood Transfusion of Chinese Academy of Medical Sciences	Tianjin	China	2
Nanfang Hospital of Southern Medical University	Guangzhou	China	37
People's hospital of Jiangsu Province	Suzhou	China	1
Sun Yat-sen University Cancer Center	Guangzhou	China	315
The First Affilated Hospital of Nanchang University	Nanchang	China	1
The First Affilated Hospital of Soochow University	Suzhou	China	1
The First Affiliated Hospital of Zhejiang University School of Medicine	Hanzhou	China	3
Union Hospital medical college Huazhong University of Science and Technology	Wuhan	China	2
Zhujiang Hospital of Southern Medical University	Guangzhou	China	33